Neutra Stock Price, News & Analysis
Company Description
Neutra (OTC Link: NTRR) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $583.6K.
NTRR stock has declined 66.7% over the past year. Shares last traded at $0.0001.
On a trailing twelve-month basis, Neutra reported revenue of $68K with net income of -$561K. The company operates at a net profit margin of -825.7%.
This page provides a comprehensive overview of NTRR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Neutra (NTRR) stock last traded at $0.0001. Over the past 12 months, the stock has lost 66.7%. At a market capitalization of $583.6K, NTRR is classified as a micro-cap stock with approximately 3.0B shares outstanding.
Latest News
Neutra has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, clinical trial. View all NTRR news →
SEC Filings
Financial Highlights
Neutra generated $68K in revenue over the trailing twelve months, retaining a 51.9% gross margin, operating income reached -$298K (-437.8% operating margin), and net income was -$561K, reflecting a -825.7% net profit margin. The company generated -$153K in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Neutra (NTRR) currently stands at 13 shares, up 100.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 100%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Neutra (NTRR) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
NTRR Company Profile & Sector Positioning
Neutra (NTRR) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing NTRR often look at related companies in the same sector, including Pharmagreen Biotech Inc (PHBI), Aequus Pharmaceu (AQSZF), Gold River Prod (GRPS), Gelstat Corp (GSAC), and Vibe Growth Corporation (VIBEF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NTRR's relative position within its industry.